Maven Ventures
VC Fund
Palo Alto, United States
Maven Ventures is a VC fund in Palo Alto focused on Software and Health Care. Maven is a seed stage venture firm investing in tech companies addressing emerging consumer behavior and trends. The Maven team identifies and backs bold founders with a vision worth fighting for, then helps founders unlock their potential to change the world, building iconic brands like Zoom and Cruise. Maven maintains a concentrated investmentstrategy, making only 6-8 core investments each year. 16% of Maven companies have achieved an exit or valuation at $500M or more, 10x industry average.
- Total investments:
- 123
- Last investment:
- Lead investor:
- 10%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Maven Ventures invests in
Stages Maven Ventures invests in
Countries Maven Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Seed
- $1.5M–$9M
- Series A
- $6.5M–$25M
- Series B
- $8M–$100M
Investment Focus
Industry
- Software 18 (15%)
- Health Care 9 (7%)
- Information Technology 8 (7%)
- Mobile 7 (6%)
- Artificial Intelligence 7 (6%)
Stage
- Seed 41 (33%)
- Series A 28 (23%)
- Series B 16 (13%)
- Series C 6 (5%)
- Funding Round 4 (3%)
Country
- United States 54 (44%)
- Canada 1 (1%)
- Israel 1 (1%)
- Vietnam 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
James Scheinman
Founding Managing Partner
|
Founding Managing Partner | Total investments: 28 | Find email | |
Robert Ravanshenas
Investment Partner
|
Investment Partner | Total investments: 9 | Find email | |
Sara Deshpande
General Partner
|
General Partner | Total investments: 19 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ease Health
|
Ease Health is a New York-based startup offering an AI-native operating system for behavioral health providers. It unifies CRM, EHR, and revenue cycle management (RCM) into a single platform to streamline operations across patient intake, clinical care, billing, and collections. The platform handles the full patient journey, consolidating 6–10typically separate systems to cut administrative burdens and enable AI-driven automation, such as documentation that reduces note-taking time by up to 50%. It supports diverse care levels, including outpatient, IOP, PHP, residential treatment, detox, inpatient psychiatry, and MAT. Additional tools include patient portals, scheduling, AI patient identification, Power BI dashboards, and compliance features like staff credential tracking. | $41M / Series A / Mar 02, 2026 | |
Medeloop
|
Medeloop accelerates breakthrough discoveries through novel deep AI model explainability techniques built on top of a comprehensive data linkage infrastructure. Medeloop is a one of a kind platform that seamlessly links, harmonizes, and analyzes massive amounts of health data. We are pioneering AI techniques that find biomarkers for clinicalresearchers, helping break down barriers to save lives.For Researchers: Our platform shortens the clinical research process using advanced AI techniques that provide research hypotheses for even the most understudied diseases.All of your data, all in one place. Cleaned, organized and analyzed. Medeloop transforms the research approach, enabling researchers to publish more and publish faster.For Research Participants: Our patient-facing app encourages the public to take control of their health and contribute to life-changing medical research.You always have access to view your health information and how it is being utilized. | $15.5M / Series A / Nov 13, 2024 | |
Fathom
|
An audiovisual recording service that integrates with both Zoom and Google Calendar. | $17M / Series A / Sep 19, 2024 | |
xAI
|
XAI is an AI company that develops a platform to accelerate human scientific discovery. The company primarily focuses on developing advanced AI systems that are truthful, competent, and maximally beneficial for all of humanity. Its mission is to understand the true nature of the universe. | $6B / Series B / May 26, 2024 | |
The Bot Company
|
The Bot Company a household robot startup. | $150M / Seed / May 13, 2024 | |
|
The Bot Company
|
The Bot Company a household robot startup. | $150M / Seed / May 13, 2024 | |
Perplexity
|
Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence. | $62.7M / Series C / Apr 23, 2024 | |
|
Perplexity
|
Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence. | $62.7M / Series C / Apr 23, 2024 | |
Lutra AI
|
Lutra AI is to simplify complex tasks that specializes in workflows, created by the platform. | $3.8M / Seed / Dec 07, 2023 | |
Warmly
|
Warmly is the first autonomous revenue orchestration platform purpose built for SMB sized revenue teams. The platform orchestrates metadata from sales enablement tools, B2B intent, and enrichment tools to identify, track, and connect with website visitors who are ready to convert. By automatically aggregating data and integrating insights fromvarious platforms, Warmly orchestrates the most effective next step to drive qualified conversations for the sales team. | $11M / Series A / Oct 19, 2023 | |
| See all 123 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Maven Ventures invest in?
Maven Ventures invests primarily in Software, Health Care and Information Technology startups, most often at Seed and Series A stage. Most of the 123 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Maven Ventures's check size?
Maven Ventures typically joins rounds of $1.5M–$9M at Seed, $6.5M–$25M at Series A and $8M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Maven Ventures participates in.
How do I contact Maven Ventures?
Public channels for Maven Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Maven Ventures?
The team at Maven Ventures includes James Scheinman (Founding Managing Partner), Robert Ravanshenas (Investment Partner) and Sara Deshpande (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
